vimarsana.com

Page 4 - மான்ட்ரியல் நரம்பியல் நிறுவனம் மருத்துவமனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Quebecer dead from blood clot identified as Francine Boyer

Quebecer dead from blood clot identified as Francine Boyer by CityNews Staff Last Updated Apr 28, 2021 at 11:55 am EDT Francine Boyer has been identified as the 54-year-old Quebecer who died after a blood clot linked to receiving the AstraZeneca COVID-19 vaccine. The first fatality in Canada linked to the shot. Photo via Canada Obituaries MONTREAL – Francine Boyerhas been identified as the 54-year-old Quebecer who died from a blood clot after she received the AstraZeneca COVID-19 vaccine. Boyer is the first fatality in Canada linked to the shot. Alain Serres, Boyer’s husband, confirmed her identity in a press release Tuesday night after Quebec Public Health Director Dr. Horacio Arruda confirmed the death at a government update on the COVID-19 situation earlier in the day.

Family of Quebec woman who died of blood clot after AstraZeneca shot urges vigilance

Family of Quebec woman who died of blood clot after AstraZeneca shot urges vigilance
montrealgazette.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from montrealgazette.com Daily Mail and Mail on Sunday newspapers.

MS Society of Canada Awards $1 Million to Research Study on Utilizing Artificial Intelligence to Support Treatment Decisions in Multiple Sclerosis

MS Society of Canada Awards $1 Million to Research Study on Utilizing Artificial Intelligence to Support Treatment Decisions in Multiple Sclerosis
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

Researchers link cellular transport pathway to aggressive brain cancer

 E-Mail IMAGE: Compared with control mice (top two rows), brain tumors (green) grow faster in the absence of Rab35 (bottom two rows). view more  Credit: ©2021 Kulasekaran et al. Originally published in Journal of Cell Biology. https://doi.org/10.1083/jcb.202004229 Researchers at McGill University have identified a new cellular pathway that limits the growth and spread of brain tumors by controlling the recycling of cell surface receptor proteins. The study, which will be published January 14 in the  ( JCB), suggests that the pathway, which involves a protein called Rab35, is defective in many patients with glioblastoma and that restoring Rab35 s activity could be a new therapeutic strategy for this deadly form of brain cancer.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.